PANX1 and neoplasm: By using shRNA knockdown to reduce Panx1 levels in B16-BL6 cells, we observed a significant reduction in their malignant properties including decreased proliferation, migration and tumor size, as well as development of fewer metastases in the liver of a chick embryo model [17].